Trademark: 87918887
Word
CLEANZINC
Status
Dead
Status Code
606
Status Date
Monday, June 20, 2022
Serial Number
87918887
Mark Type
4000
Filing Date
Sunday, May 13, 2018
Published for Opposition
Tuesday, March 19, 2019
Abandoned Date
Monday, June 20, 2022

Trademark Owner History
AZ Solutions, LLC - Owner At Publication

Classifications
5 Antiseptic preparations; Antiseptics; Chemical preparations for pharmaceutical or medical purposes, namely, for treatment of wounds, ulcers, surgical wounds, and abscesses; Chemical reagents for medical or veterinary purposes; Irrigating solutions for eye use; Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical preparation for skin care; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of abscesses, ulcers, wounds, burns, other infectious processes, skin injuries; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases; Wound dressings; Antibacterial pharmaceuticals; Cleansing solutions for medical use; Dermatological pharmaceutical products; Disposable wipes impregnated with disinfecting chemicals or compounds therefor for use in hospitals; Dressings for wounds; Dressings for surgery; Dressings for ulcers; Dressings for abscesses; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with pharmaceutical preparations in the nature of activated zinc solution for the treatment of wounds, ulcers, surgical incisions, infections and abscesses; Intravenous bags sold filled with activated zinc solution pharmaceutical preparations in the nature of activated zinc solution for the treatment of infections wounds, ulcers, surgical incisions, infections and abscesses; Medical and surgical dressings; Medical cleansers for skin and wounds; Pharmaceutical preparations for wounds; Pharmaceutical preparations for ocular or intraocular surgery; Sponges impregnated with antiseptics; Sponges impregnated with disinfecting chemicals or compounds therefor for use in hospitals and clinics for the treatment of wounds, ulcers, surgical incisions, infections and abscesses; Syringes sold filled with pharmaceutical preparations in the nature of activated zinc solution for the treatment of wounds, ulcers, surgical incisions, infections and abscesses; Therapeutic pharmaceutical for the treatment of ulcers, wounds, abscesses, other infectious processes; all of the aforementioned goods containing zinc

Trademark Events
Jun 21, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 20, 2022
Abandonment - No Use Statement Filed
Feb 2, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 1, 2022
Sou Extension 5 Granted
Nov 15, 2021
Sou Extension 5 Filed
Jan 31, 2022
Case Assigned To Intent To Use Paralegal
Dec 21, 2021
Notice Of Revival - E-Mailed
Dec 21, 2021
Extension Received With Teas Petition
Dec 21, 2021
Petition To Revive-Granted
Dec 21, 2021
Teas Petition To Revive Received
Dec 20, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 20, 2021
Abandonment - No Use Statement Filed
May 18, 2021
Notice Of Approval Of Extension Request E-Mailed
May 14, 2021
Sou Extension 4 Granted
May 14, 2021
Sou Extension 4 Filed
May 14, 2021
Teas Extension Received
Nov 10, 2020
Notice Of Approval Of Extension Request E-Mailed
Nov 6, 2020
Sou Extension 3 Granted
Nov 6, 2020
Sou Extension 3 Filed
Nov 6, 2020
Teas Extension Received
May 16, 2020
Notice Of Approval Of Extension Request E-Mailed
May 14, 2020
Sou Extension 2 Granted
May 14, 2020
Sou Extension 2 Filed
May 14, 2020
Teas Extension Received
Nov 14, 2019
Notice Of Approval Of Extension Request E-Mailed
Nov 12, 2019
Sou Extension 1 Granted
Nov 12, 2019
Sou Extension 1 Filed
Nov 12, 2019
Teas Extension Received
May 14, 2019
Noa E-Mailed - Sou Required From Applicant
Mar 19, 2019
Official Gazette Publication Confirmation E-Mailed
Mar 19, 2019
Published For Opposition
Feb 27, 2019
Notification Of Notice Of Publication E-Mailed
Feb 14, 2019
Law Office Publication Review Completed
Feb 14, 2019
Assigned To Lie
Jan 29, 2019
Approved For Pub - Principal Register
Dec 28, 2018
Teas/Email Correspondence Entered
Dec 27, 2018
Correspondence Received In Law Office
Dec 27, 2018
Teas Response To Office Action Received
Sep 17, 2018
Notification Of Non-Final Action E-Mailed
Sep 17, 2018
Non-Final Action E-Mailed
Sep 17, 2018
Non-Final Action Written
Sep 5, 2018
Assigned To Examiner
May 20, 2018
New Application Office Supplied Data Entered In Tram
May 16, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24